Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOLAR-1: LDV/SOF + RBV in Advanced Liver Disease/Transplant
NCT01938430Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Sep 2013
- Primary completion
- Jan 2015
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of Harvoni in hepatitis C virus infection, sponsored by Gilead Sciences. Started Sep 2013; status: completed.
02
Drugs
Harvoni
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT01938430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01938430.